The National Health Surveillance Agency (ANVISA in Portuguese) held a virtual sectoral dialog on dietary supplements containing turmeric-derived ingredients on March 17, 2026. The meeting brought together 696 participants from different sectors of society and aimed to present the regulatory proposal on the topic, clarify doubts, and gather contributions from stakeholders.

During the meeting, the international and national context related to the use of ingredients derived from Curcuma longa L. was addressed, including safety evidence, monitoring data, and current usage conditions in dietary supplements. The main proposed modifications to Normative Instruction No. 28/2018 were also presented, focusing on the inclusion of warnings on the labeling and the clarification of curcumin limits. During the participation phase, aspects such as the scope of the proposal, the interpretation of regulatory limits, the repercussions on already regulated products, and the adaptation period were addressed, in addition to technical issues related to the safety and use of these ingredients.

Anvisa provides the following materials for consultation and monitoring of the issue: